I've been reviewing the recent Wall Street Journal report by Christopher Weaver on the new prenatal testing for Down syndrome. Weaver reports on questions raised by the new testing. The accompanying video to the report (available above) distills the worry down to a few simple statements. But are these statements the real worry with the new prenatal testing for Down syndrome? Continue Reading
What price to do prenatal testing right?
The recent Wall Street Journal report by Christopher Weaver on Non-Invasive Prenatal Screening (NIPS) included a number that suggests how much money is in the NIPS market. But what else should that money be going towards? Continue Reading
Non-NIPS tests for Down syndrome are “tarot cards”
Continuing the examination of Christopher Weaver's recent report on NIPS in the Wall Street Journal, one quote jumped off the page when I read it. Did you know that screening tests that are not NIPS are as helpful as "tarot cards"? Continue Reading
Worries about new prenatal screen for Down syndrome
Earlier this month, the Wall Street Journal published a report on worries being raised about the new prenatal screening testing for Down syndrome. What are these worries (and are these the only ones worth reporting on)? Continue Reading
Recent Comments